Charak Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 28 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 27.31%
(FY 2023)
- Profit 29.11%
(FY 2023)
- Ebitda -6.76%
(FY 2023)
- Net Worth -30.55%
(FY 2023)
- Total Assets -28.86%
(FY 2023)
About Charak Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nimish Kishor, Ram Shroff, Raj Shroff, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24200MH1996PTC101559
- Company No.
101559
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Charak Healthcare?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nimish Kishor  | Director | 02-Aug-1996 | Current |
| Ram Shroff | Director | 02-Aug-1996 | Current |
| Raj Shroff | Director | 02-Aug-1996 | Current |
| Pulin Harshad | Director | 02-Aug-1996 | Current |
| Vikram Kishor | Director | 02-Aug-1996 | Current |
Financial Performance and Corporate Structure Insights of Charak Healthcare.
Charak Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.31% increase. The company also saw a substantial improvement in profitability, with a 29.11% increase in profit. The company's net worth observed a substantial decline by a decrease of 30.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Charak Healthcare?
In 2023, Charak Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vedistry Private LimitedActive 8 years 29 daysNimish Kishor, Ram Shroff and 3 more are mutual person
Charak Pharma Private LimitedActive 24 years 6 monthsNimish Kishor, Ram Shroff and 3 more are mutual person
Creme-De-La-Creme Private LimitedActive 29 years 6 monthsNimish Kishor, Ram Shroff and 3 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Charak Healthcare?
Unlock and access historical data on people associated with Charak Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Charak Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Charak Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
